Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical lignocaine and diltiazem for pain after haemorrhoid banding
ACTRN12620000044921Phase 3Completed
- Sponsor
- Hunter New England Local Health District
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of lidocaine and diltiazem in hemorrhoid, sponsored by Hunter New England Local Health District. Started Mar 2021; status: completed.
02
Drugs
lidocainediltiazem
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ACTRN12620000044921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000044921.